The biggest problem now is that the SPAC frenzy has come and gone and almost all of the SPACs from the last couple of years have had their share prices crushed, regardless of the merits of the individual companies. So it's very late in the game for a SPAC.
I'd much rather see an organic Nasdaq uplisting, which could take quite some time, but maybe Wayne thinks this is his best shot at accessing US capital in a timely fashion.
- Forums
- ASX - By Stock
- AVR
- Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger, page-21
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.43 |
Change
-0.480(4.84%) |
Mkt cap ! $202.9M |
Open | High | Low | Value | Volume |
$9.50 | $9.61 | $9.31 | $124.0K | 13.08K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16 | $9.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.46 | 450 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 377 | 9.410 |
1 | 6 | 9.320 |
1 | 99 | 9.310 |
1 | 2000 | 9.300 |
2 | 1044 | 9.250 |
Price($) | Vol. | No. |
---|---|---|
9.490 | 144 | 3 |
9.500 | 1282 | 3 |
9.530 | 180 | 1 |
9.540 | 180 | 1 |
9.550 | 180 | 1 |
Last trade - 13.31pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online